LINQ II Insertable Cardiac Monitor

by Medtronic  · Based in Ireland → — Engineering the extraordinary.
Cardiology

Documentation ProvidedRegulatory Status Disclosed

Overview

The Medtronic LINQ II™ Insertable Cardiac Monitor (ICM) is a state-of-the-art, miniaturized device designed for long-term, continuous heart monitoring. Approximately one-third the size of a AAA battery, it is subcutaneously implanted in a minimally invasive procedure, offering discreet and persistent monitoring for up to 4.5 years. This device is indicated for adult patients and pediatric patients aged two years and older who are at increased risk of cardiac arrhythmias or experience transient symptoms such as dizziness, palpitations, syncope, and chest pain that may suggest an arrhythmia.

A core innovation of the LINQ II ICM is its integration with AccuRhythm™ AI algorithms. This groundbreaking artificial intelligence platform applies deep learning to ECG data flowing into the Medtronic CareLink™ network, significantly enhancing the accuracy of atrial fibrillation (AF) and Pause detection. The cloud-based AI system is proven to reduce false alerts by over 91% while preserving nearly all true alerts, thereby streamlining clinician workflows and allowing more time for critical patient care.

The LINQ II system offers flexible and convenient remote patient management. Patients can transmit device data automatically via the MyCareLink Heart™ mobile app (compatible with both iOS and Android smartphones/tablets) or the MyCareLink Relay™ home communicator. This remote connectivity, including the first-ever remote programming capability for an ICM, allows clinicians to optimize device settings post-insertion without the need for in-office visits, reducing patient burden and improving compliance. The device is also MRI-compatible (at 1.5 and 3.0T) and features end-to-end encryption to ensure the security and privacy of patient data.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • AccuRhythmu2122 AI algorithms for enhanced accuracy
  • Remote programming capability
  • Up to 4.5 years of continuous monitoring
  • MRI compatibility (1.5 and 3.0T)
  • MyCareLink Heartu2122 mobile app for data transmission
  • MyCareLink Relayu2122 home communicator option
  • Innovative PVC detection algorithm
  • Pediatric indication (ages 2+)
  • End-to-end data encryption
  • Minimally invasive implantation

Use Cases

  • Long-term monitoring for cardiac arrhythmias
  • Diagnosing unexplained syncope (fainting)
  • Investigating palpitations and chest pain
  • Managing atrial fibrillation (AFib)
  • Detecting AFib after cryptogenic stroke
  • Reducing false alerts in cardiac monitoring

What Physicians Need to Know

ECG/EKG Analysis Capability
The LINQ II ICM records subcutaneous ECGs. It offers an enhanced ECG experience to aid in clinical adjudication, providing clarity without compromise.
Echocardiography AI Features
The Medtronic LINQ II Insertable Cardiac Monitor does not have echocardiography AI features. It is an insertable cardiac monitor that records subcutaneous ECG.
Cardiac CT/MRI Analysis
The LINQ II ICM is MRI Conditional at ≤ 3T with no post-insertion waiting required. Studies have shown that the LINQ device does not produce clinically significant artifact on either thoracic CT or cardiac MRI imaging, even when artifact extends into the intrathoracic space.
Arrhythmia Detection Accuracy
The LINQ II ICM utilizes AccuRhythm™ AI algorithms to improve the accuracy of heart rhythm data. These algorithms have been shown to reduce false alerts for atrial fibrillation (AF) and pause by 74.1% and 97.4% respectively, while preserving over 99% of true alerts. The LINQ II ICM has the lowest published rates of AF false detections compared to previous ICMs. The LINQ family of ICMs offers a high AF detection accuracy rate of 99.7%.
Heart Failure Risk Prediction
The LINQ family of ICMs, including LINQ II, can be used to identify patients at high risk of worsening heart failure. Physiological information from sensors within the ICM can be used to develop an ambulatory heart failure risk score (HFRS) to identify patients at high risk of an impending worsening heart failure event. Insights from the ALLEVIATE-HF clinical trial showed a high rate of actionable arrhythmias in heart failure patients monitored with Reveal LINQ ICMs, leading to therapeutic intervention.
Cardiac Monitoring Integration
The LINQ II ICM system integrates with the MyCareLink Heart™ mobile app, allowing patients to use their smartphone to automatically transfer device data to their doctor. It also connects to the Medtronic CareLink™ Network for remote monitoring and management. The device uses BlueSync™ technology for secure, wireless communication via Bluetooth® Low Energy.
AHA/ACC Guideline Alignment
The LINQ II ICM provides continuous, long-term monitoring for patients with abnormal heart rhythms, including atrial fibrillation (AF), syncope, and cryptogenic stroke, which aligns with guidelines for extended monitoring in these conditions.
Real-Time Alert Capability
The LINQ II ICM system provides timely alerts of clinically relevant patient data to clinicians. The AccuRhythm™ AI algorithms reduce false alerts while retaining true alerts, allowing clinicians to manage diagnostic yield. Event notifications can trigger actionable alerts.
Physician Tip

The LINQ II ICM offers continuous, long-term monitoring for up to 4.5 years, providing extensive data for diagnosing infrequent arrhythmias and managing chronic cardiac conditions. The AccuRhythm™ AI algorithms significantly reduce false alerts, minimizing review burden and allowing more focus on clinically relevant events. Remote programming capabilities and seamless integration with the MyCareLink Heart™ app and CareLink™ Network can reduce the need for in-office visits and streamline workflows. Consider the LINQ II ICM for patients with unexplained syncope, palpitations, chest pain, or cryptogenic stroke, as well as for long-term monitoring in heart failure patients to detect actionable arrhythmias. The device is MRI-conditional, offering flexibility for future imaging needs.

The LINQ II ICM integrates with the MyCareLink Heart™ mobile app for automatic data transfer via Bluetooth® to the Medtronic CareLink™ Network. This allows for remote monitoring and management by clinicians. The system also supports a MyCareLink Relay™ home communicator for bedside use if a smartphone is not compatible or preferred.

Details

Category Cardiology AI, Clinical Decision Support & Reference
Pricing Unknown
DeploymentSubcutaneous implant with remote monitoring via mobile app or home communicator.
Mobile AppMyCareLink Heart™ mobile app (for patients) and Reveal LINQ™ Mobile Manager app (for healthcare professionals)
Compliance
BAA AvailableUnknown
HIPAA CompliantUnknown
FDA Status Cleared AI-estimated
Integrations
EHR Not specified
Specialties Cardiology

Support & Reliability

FDA clearance history

This product’s FDA authorization. From FDA’s list of AI-enabled medical devices; each number links to FDA’s record.

Decision dateNumberName as listed by FDA
2023-12-06K233562 510(k)LINQ II Insertable Cardiac Monitor

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate LINQ II Insertable Cardiac Monitor

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money
No press coverage or publications on file yet. Know of some? Suggest an edit →

Videos

Product demos, reviews, and walkthroughs for LINQ II Insertable Cardiac Monitor.

View all on YouTube

Frequently Asked Questions

The LINQ II ICM incorporates AccuRhythm™ AI algorithms, a groundbreaking platform that applies deep learning artificial intelligence to the data flowing into the CareLink™ network. These AI algorithms enhance the accuracy of heart rhythm detection, particularly for atrial fibrillation (AF) and pause episodes, by reducing false positives and preserving true alerts.
For physicians, the AccuRhythm™ AI algorithms significantly reduce false alerts (by over 91% for AF and pause) which can save clinics hundreds of hours annually in reviewing cardiac monitoring reports, allowing more focus on critical patient care. For patients, this means more accurate diagnoses and treatment decisions, as the system provides clearer, more reliable data.
Potential risks associated with the LINQ II ICM include infection at the surgical site, device migration, erosion of the device through the skin, and/or sensitivity to the device material. Additionally, accessories used with the LINQ II may experience connectivity or performance issues.
The LINQ II system offers flexible monitoring options to enhance patient compliance, including a smartphone/tablet app (MyCareLink Heart™) or a home communicator (MyCareLink Heart Relay™) that automatically collect and send heart rhythm data to the physician. Automatic smartphone notifications also help patients stay connected and reduce the need for manual transmissions.
While the LINQ II is a leading ICM, other insertable cardiac monitors exist, such as the BIOMONITOR III. Additionally, traditional monitoring methods like Holter monitors and external event monitors are alternatives, though ICMs provide data over longer periods and have a higher diagnostic yield for infrequent symptoms.

Related Tools

Stethophone Pro
Sparrow Acoustics
Cardiology AI
Stethophone Pro transforms smartphones into advanced cardiac screening tools, enabling clinicians to capture, interpret, and visualize heart sounds for early detection of cardiovascular diseases.
ACUSON Sequoia Diagnostic Ultrasound System, ACUSON Sequoia Select Diagnostic Ultrasound System, ACUSON Origin Diagnostic Ultrasound System, ACUSON Origin ICE Diagnostic Ultrasound System
Siemens Medical Solutions, USA
Cardiology AI
Siemens Healthineers offers advanced AI-powered ultrasound systems, including the ACUSON Origin for comprehensive cardiovascular care and the ACUSON Sequoia for high-performance general imaging with BioAcoustic™ technology.
syngo.via MI Workflows, syngo MBF
Siemens Medical Solutions USA
Cardiology AI
syngo.via MI Workflows, syngo MBF is an intelligent, integrated imaging software that helps address the challenges of interpreting, managing, and sharing complex data from molecular imaging scanners, providing automated workflows and advanced visualization for various clinical applications.
syngo.via MI WorkFlows, Scenium, syngo MBF
Siemens Medical Solutions USA
Cardiology AI
syngo.via MI Workflows, Scenium, and syngo MBF are medical diagnostic post-processing applications for viewing, manipulation, quantification, analysis, and comparison of PET or nuclear-medicine functional data with CT or MR anatomical data across timepoints, supporting disease management and radiotherapy treatment planning by trained healthcare professionals.
ACUSON Sequoia Diagnostic Ultrasound System, ACUSON Sequoia Select Diagnostic Ultrasound System, ACUSON Origin Diagnostic Ultrasound System
Siemens Medical Solutions USA
Cardiology AI
Siemens Healthineers offers the ACUSON Sequoia, ACUSON Sequoia Select, and ACUSON Origin ultrasound systems, providing advanced imaging for various medical needs. The Sequoia line focuses on high-resolution imaging with deep penetration and reduced variability, while the AI-powered ACUSON Origin specializes in comprehensive cardiovascular diagnostics and interventions.
R30 Diagnostic Ultrasound System
Samsung Medison Co.
Cardiology AI
The Samsung Medison R30 Diagnostic Ultrasound System is a general-purpose, mobile, software-controlled diagnostic ultrasound system that offers a wide range of imaging capabilities and analysis tools for various clinical applications.

See all Cardiology AI tools →

More from Medtronic

Aurora EV ICD (DVEA3E4)
Medtronic
Cardiology AI
The Aurora EV-ICD™ system is a first-of-its-kind extravascular defibrillator that treats sudden cardiac arrest and abnormal heart rhythms with defibrillation and anti-tachycardia pacing (ATP) in a single device. Its lead is placed outside the heart and veins, under the breastbone, to potentially reduce complications associated with transvenous leads.
Guardian Connect
Medtronic
Endocrinology & Metabolic AI
The Medtronic Guardian Connect system is a continuous glucose monitoring (CGM) system that provides real-time glucose level monitoring and alerts on mobile devices, with AI capabilities for predicting blood glucose changes.
Reveal LINQ
Medtronic
Cardiology AI
Medtronic Reveal LINQ is a tiny, implantable cardiac monitor that continuously records ECG for up to three years, utilizing AccuRhythm™ AI algorithms to accurately detect and diagnose cardiac arrhythmias, including atrial fibrillation, cryptogenic stroke, and unexplained syncope.

View company profile →

Suggest an Edit → | Report an issue | Last Verified: 2026-11-15 | First Added: 2026-04-19
AI Tool Finder
AI-powered search. Results may not be comprehensive.